Osteometabolix Pharmaceuticals Inc. (OMX) is a university spin-off company focused on the development, formulation and evaluation of bone-targeting biologics for bone conditions such as Osteoporosis, Paget’s disease, and Osteoarthritis.
To request access, simply fill out the form below and we will contact you.
Password must:
• Be at least 12 characters in length
• Contain a lowercase letter (a-z)
• Contain an uppercase letter (A-Z)
• Contain a numeral (0-9)
• Contain a special character (%, $, !, @)
By signing up for this account you agree to the Terms of Service